The best treatment for elderly patients with advanced non–small-cell lung cancer (NSCLC)
is still debated. To guide clinical management of these patients and suggest the priorities for …

Purpose Elderly patients often have comorbidities and other characteristics that make the
selection of treatment daunting. Methods We have reviewed the available evidence in the …

Purpose: to assess the prevalence and correlates of fatigue in cancer patients aged 60 and
older during outpatient treatment with chemotherapy or pamidronate. Patient and Methods …

Chemotherapy for elderly patients with non-small cell lung cancer (NSCLC) has been
questioned due to the perceived potential for higher toxicity in this population, possibly …

Purpose: The aim of the present study was to identify elderly-specific clinical trials for
advanced non-small cell lung cancer (NSCLC) and to clarify the study design and patient …

Vinorelbine is a semisynthetic vinca alkaloid that is effective as monotherapy in elderly
patients with advanced non-small cell lung cancer (NSCLC). In the large comparative …

Objectives: The incidence of non-small cell lung cancer (NSCLC) is increasing among the
elderly. We studied the toxicity and efficacy of a weekly schedule of gemcitabine and …

The elderly and patients with Performance Status (PS) of 2, constitute the so-called special
patient population. The tolerability of chemotherapy in this population is globally worse, and …

In the last few years it has become evident that the elderly lung cancer patient represents a
peculiar individual with regard to both the tolerance to the tumor and its treatment. Age per …

Lung cancer is a prevalent malignancy disproportionately affecting the elderly, and in our
aging societies will only increase in magnitude. Physicians typically assume that elderly …